Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Arabidopsis thaliana LONG HYPOCOTYL5 (HY5) is a positive regulator of the light signaling pathway. The hy5 mutant has an elongated hypocotyl in all light conditions, whereas the hy5 homolog (hyh) mutant has a very weak phenotype, but only in blue light. However, overexpression of HYH rescues the elongated hypocotyl phenotype in the hy5 null mutant. Here, we report the identification of four HYH splicing variants in Arabidopsis. Alternative splicing in the 5' region of the HYH gene occurred such that the proteins encoded by all four HYH variants retained their bZIP domain. In hypocotyl tissue, transcript levels of HYH.2, HYH.3, and HYH.4 were higher than those of HYH.1. Like HY5, all HYH variants were induced by light. Functional analysis of the four HYH variants, based on their abilities to complement the hy5 mutant, indicated that they have similar roles in hypocotyl development, and may function redundantly with HY5. Our results indicate that the bZIP domain in HYH is critical for the function of four variants in the compensation of hy5 mutant in hypocotyl development. Additionally, while HY5/HYH is found in plant species ranging from green algae to flowering plants, the potential alternative splicing events are distinct in different species, with certain HYH variants found with greater frequency in some species than others.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.gene.2017.04.001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Identification of a targetable JAK-STAT enriched androgen receptor and androgen receptor splice variant positive triple-negative breast cancer subtype.
Cell Rep
December 2023
Department of Medicine, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38103, USA; UTHSC Center for Cancer Research, University of Tennessee Health Science Center, Memphis, TN 38103, USA. Electronic address:
Article Synopsis
- Triple-negative breast cancer (TNBC) lacks targeted treatments and includes a subtype called luminal androgen receptor (LAR) TNBC, which represents 15% of cases and is characterized by high levels of androgen receptor (AR) expression.
- Research shows that about 80% of TNBC cases express AR, with around 20% also showing AR splice variants (AR-SVs), particularly noted in specimens from African American women and linked to more aggressive cancer traits.
- The study indicates that AR and AR-SV expressing TNBC can potentially be targeted with specific drugs like AR degraders or JAK inhibitors, and suggests a growth-promoting relationship between AR and JAK-STAT signaling pathways.
SARS-CoV-2 viruses are highly transmissible and immune evasive. It is critical to develop broad-spectrum prophylactic and therapeutic antibodies for potential future pandemics. Here, we used the phage display method to discover nanobodies (Nbs) for neutralizing SARS-CoV-2 viruses especially Omicron strains.
View Article and Find Full Text PDFInhibiting androgen receptor splice variants with cysteine-selective irreversible covalent inhibitors to treat prostate cancer.
Proc Natl Acad Sci U S A
January 2023
Department of Medicine, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38103.
Androgen receptor (AR) and its splice variants (AR-SVs) promote prostate cancer (PCa) growth by orchestrating transcriptional reprogramming. Mechanisms by which the low complexity and intrinsically disordered primary transactivation domain (AF-1) of AR and AR-SVs regulate transcriptional programming in PCa remains poorly defined. Using omics, live and fixed fluorescent microscopy of cells, and purified AF-1 and AR-V7 recombinant proteins we show here that AF-1 and the AR-V7 splice variant form molecular condensates by liquid-liquid phase separation (LLPS) that exhibit disorder characteristics such as rapid intracellular mobility, coactivator interaction, and euchromatin induction.
View Article and Find Full Text PDFIntranasal M2SR (M2-Deficient Single Replication) H3N2 Influenza Vaccine Provides Enhanced Mucosal and Serum Antibodies in Adults.
J Infect Dis
December 2022
FluGen, Inc, Madison, Wisconsin, USA.
Article Synopsis
- A phase 1b study evaluated the safety and immune response of an intranasal M2-deficient single replication (M2SR) influenza vaccine in adults aged 18-49.
- Subjects received two doses of the vaccine, with results showing significant increases in neutralizing antibodies after higher doses; 80.6% demonstrated a response after the 109 TCID50 dose.
- The vaccine was well tolerated and elicited both mucosal and cellular immune responses, suggesting its potential effectiveness against drifted H3N2 influenza strains.
Stroke genetics informs drug discovery and risk prediction across ancestries.
Nature
November 2022
Bordeaux Population Health Research Center, University of Bordeaux, Inserm, UMR 1219, Bordeaux, France.
Previous genome-wide association studies (GWASs) of stroke - the second leading cause of death worldwide - were conducted predominantly in populations of European ancestry. Here, in cross-ancestry GWAS meta-analyses of 110,182 patients who have had a stroke (five ancestries, 33% non-European) and 1,503,898 control individuals, we identify association signals for stroke and its subtypes at 89 (61 new) independent loci: 60 in primary inverse-variance-weighted analyses and 29 in secondary meta-regression and multitrait analyses. On the basis of internal cross-ancestry validation and an independent follow-up in 89,084 additional cases of stroke (30% non-European) and 1,013,843 control individuals, 87% of the primary stroke risk loci and 60% of the secondary stroke risk loci were replicated (P < 0.
View Article and Find Full Text PDF